The flow-cytometric DNA content of the plasma cells of patients with multiple myeloma is a prognostic factor: a single institution experience

Abstract excerpt

The flow-cytometric DNA content in the plasma cells of patients with multiple myeloma has been studied as a prognostic factor and contrasting results have been found. In a group of 45 patients with myeloma from a single institution, the DNA content of the malignant plasma cells was studied by means of flow cytometry: no patients were found to have hypodiploid DNA content, 14 patients had hyperdiploid DNA, and 31...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Multiple Myeloma Research and Treatments
• Share to PI3K/AKT/mTOR signaling in cancer
• Share to Protein Degradation and Inhibitors